{"id":753147,"date":"2023-05-01T13:00:08","date_gmt":"2023-05-01T17:00:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/"},"modified":"2023-05-01T13:00:08","modified_gmt":"2023-05-01T17:00:08","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BALA CYNWYD, Pa., May  01, 2023  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UnKWBPnLE2QuEYoHDGfA7bddrbp5dLk8L02NfevCJ8Gj_G9Q-imtf0A0GL1RGoRtLPBAkcTlwnEBr1YrM_mdLkhRDX7k3_R550X_A9R9Gc8=\" rel=\"nofollow noopener\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hDhK9GlAJt1TNE3yPs8YAP4rsHk7CK3SXE_l03KtgJFb9ZN4BrIo6DQL7dCQueTNlZKi0k4AWbEkQcFCMShPoPEy10AFLw_4zveGbCQcaq5kZyNN3kJxfQrLdZzzpHr1\" rel=\"nofollow noopener\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Spectrum will be acquired by Assertio Holdings, Inc. (\u201cAssertio\u201d) (Nasdaq &#8211; ASRT). Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own, implying an upfront value of $1.14 per Spectrum share (approximately $248 million) based on Assertio\u2019s stock price on April 24, 2023. Additionally, Spectrum stockholders will receive one CVR per Spectrum share entitling them to receive up to an additional $0.20 per share in total (approximately $43 million), payable in cash or stock at Assertio\u2019s election. Following the close of the transaction, Assertio stockholders will own approximately 65% of the combined company, and Spectrum stockholders will own approximately 35%, on a fully diluted basis. The investigation concerns whether the Spectrum Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Assertio is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0pIc-PdZqtqNcthlMtQRydrWcjGhI_lxyNIR9h-LRZdkRw5NKTdKxmzziGeGXeWDLr4SF1P_HgwS-FFbQ7dYgl0T3D1BaybBr5Nq0CXBaEZMMUhjFJZ6Hqy3nUWKl77DrrumA0vjWfbu76UGGXlC1WqETJXrOK1gx6aBH8BAFsFR8ulV1978v1R1K9aGoN9rFeaRkcFmtsZ6RrAYF2KOpkT0nYFyvJq1flnVFQxEeU8=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/spectrum-pharmaceuticals-inc-nasdaq-sppi\/<\/a>.<\/p>\n<p>\n        <strong>BELLUS Health Inc (Nasdaq \u2013 BLU)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, BELLUS will be acquired by GSK Plc (NYSE &#8211; GSK). BELLUS shareholders will receive $14.75 cash for each BELLUS common share, for a total equity value of approximately $2.0 billion. The investigation concerns whether the BELLUS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether GSK Plc is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0pIc-PdZqtqNcthlMtQRydrWcjGhI_lxyNIR9h-LRZcaYw8sKylSIMcvo-dk-GJFiR-Tp7c8ggMfq3EAi1ZKT-jVJB0EGVfCKxpcJQxPN1P8L_WzgEE7oB1HYPnjy0Ouo41U98OHFb7P9T8SdOve_IX1A3W9RJwQS9-xda0WfaQqVhYNrsi8dua4gy4gruynf5QckdZAHf6-hjURd6osWQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/bellus-health-inc-nasdaq-blu\/<\/a>.<\/p>\n<p>\n        <strong>Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Prometheus will be acquired by Merck (NYSE &#8211; MRK). Prometheus shareholders will receive $200.00 cash for each Prometheus common share, for a total equity value of approximately $10.8 billion. The investigation concerns whether the Prometheus Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Merck is paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0pIc-PdZqtqNcthlMtQRydrWcjGhI_lxyNIR9h-LRZdqq9HnRERHgtfXYvJS8lFAvBFSrln3_1o-Q3hZhts-n3wqUvaWAbdpgS0zLbSjrxAcC1ANqYNoBQn3l4suqqhE2vm8J_PdppYrfIIU2Z--b4s6E-8AGGpLlChSquZ47qVSRcewkdcGbmnzHCoiUqYc06kTspAi2nKzc0_Uiu5f6j1dg9dhIJkMD9tkaVedqrk=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/prometheus-biosciences-inc-nasdaq-rxdx\/<\/a>.<\/p>\n<p>\n        <strong>Univar Solutions Inc. (NYSE &#8211; UNVR)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Univar will be acquired by funds managed by affiliates of Apollo (NYSE \u2013 APO) (the \u201cApollo Funds\u201d) in an all-cash transaction that values the Company at an enterprise value of approximately $8.1 billion. The agreement provides that Univar Solutions shareholders will receive $36.15 per share in cash. The investigation concerns whether the Univar Solutions Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Apollo Funds are paying too little for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0pIc-PdZqtqNcthlMtQRydrWcjGhI_lxyNIR9h-LRZfftm7I3LNrX0eCtkT8bBr-q3NA7prcvBcaYvvSAIPahDr_QPkVe2I-FQwUrtK6VgHJKGYTJ_4jjxU8C85RSJPdJj2WJzzH_igU0a5HPgFmrJWZEjgVGO5iPnm_W8X3Rk_6M4DsAxjQAQiZM68gbtCQrjUzvMIvLQN8QktR247TeQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/univar-solutions-inc-nyse-unvr\/<\/a>.<\/p>\n<p>Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzM2NWQzMTMtNjE3Yy00YjQwLWIzZmEtZDBlMzNhMmRmNjUyLTExOTk4MzE=\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI) Under the terms of the Merger Agreement, Spectrum will be acquired by Assertio Holdings, Inc. (\u201cAssertio\u201d) (Nasdaq &#8211; ASRT). Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own, implying an upfront value of $1.14 per Spectrum share (approximately $248 million) based on Assertio\u2019s stock price on April 24, 2023. Additionally, Spectrum stockholders &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753147","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI) Under the terms of the Merger Agreement, Spectrum will be acquired by Assertio Holdings, Inc. (\u201cAssertio\u201d) (Nasdaq &#8211; ASRT). Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own, implying an upfront value of $1.14 per Spectrum share (approximately $248 million) based on Assertio\u2019s stock price on April 24, 2023. Additionally, Spectrum stockholders &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T17:00:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)\",\"datePublished\":\"2023-05-01T17:00:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/\"},\"wordCount\":579,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\",\"datePublished\":\"2023-05-01T17:00:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI) Under the terms of the Merger Agreement, Spectrum will be acquired by Assertio Holdings, Inc. (\u201cAssertio\u201d) (Nasdaq &#8211; ASRT). Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own, implying an upfront value of $1.14 per Spectrum share (approximately $248 million) based on Assertio\u2019s stock price on April 24, 2023. Additionally, Spectrum stockholders &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T17:00:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)","datePublished":"2023-05-01T17:00:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/"},"wordCount":579,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE - UNVR) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=","datePublished":"2023-05-01T17:00:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTE1MSM1NTY3MzgwIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-spectrum-pharmaceuticals-inc-nasdaq-sppi-bellus-health-inc-nasdaq-blu-prometheu-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq \u2013 SPPI), BELLUS Health Inc (Nasdaq \u2013 BLU), Prometheus Biosciences, Inc. (Nasdaq \u2013 RXDX), Univar Solutions Inc. (NYSE &#8211; UNVR)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753147"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}